• Radioiodinated Balsalazide for Colitis Imaging

  2026-08-24

  The reference study developed and evaluated radioiodinated balsalazide as a colon-targeted tracer for ulcerative colitis in mice. Its optimized chloramine-T labeling workflow, 24-hour stability assessment, and strong uptake in ulcerated colon provide a useful preclinical framework for inflammation research, while also highlighting important limits in receptor specificity and translation to human imaging.

• Radioiodinated Balsalazide for UC Imaging in Mice

  2026-08-24

  Sanad and colleagues developed and evaluated radioiodinated balsalazide as a colon-associated tracer for ulcerative colitis imaging in mice. The work combines optimized chloramine-T radioiodination, 24-hour stability testing, and comparative biodistribution to support a preclinical imaging workflow rather than a clinically validated diagnostic method.

• α2-Adrenergic Receptor Agonist Assay Guide

  2026-08-23

  Explore how 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine can support α2-adrenergic receptor signaling studies. This assay-focused guide connects compound handling with immune, tumor-cell, and translational readout decisions.

• Recombinant Mouse M-CSF for Macrophage Assays

  2026-08-22

  Build more consistent mouse macrophage, osteoclast, fibrosis, and tumor-cell co-culture models with a defined, tag-free M-CSF input. This guide connects practical dosing and handling decisions to the IGF2BP1–THBS1–TLR4 findings reported in pulmonary fibrosis research.

• Baicalin Methyl Ester and Gut Barrier Translation

  2026-08-22

  Baicalin methyl ester is an esterified derivative of baicalin with preclinical evidence for protecting intestinal epithelial barrier integrity after LPS challenge. This article interprets its P65/TNF-α/MLCK/ZO-1 mechanism, evaluates the strength and limits of the evidence, and provides practical guidance for translational intestinal inflammation research.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-21

  Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used for research workflows only, not for diagnostic, therapeutic, or medical applications, and no directly matched paper-specific validation is supplied.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-20

  A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of transcriptomic discovery, molecular validation, and macrophage-specific RXRα knockdown provides a useful framework for testing how nuclear receptor signaling connects vascular inflammation with protein ubiquitination.

• N-octanoyl-L-Homoserine lactone: Assay Logic

  2026-08-20

  N-octanoyl-L-Homoserine lactone, or C8-HSL, connects bacterial quorum sensing with host-cell signaling. This assay-first guide explains how to distinguish biofilm, virulence, and cancer-cell phenotypes while translating recent PI3K/AKT/ERK findings into better experimental decisions.

• Lenalidomide and DOT1L: Reprogramming Myeloma Immunity

  2026-08-19

  Lenalidomide research is moving beyond broad immunomodulation toward biomarker-guided combination biology. This thought-leadership guide examines how DOT1L-dependent innate immune signaling may shape CC-5013 response in multiple myeloma and translates the findings into practical assay and development strategies.

• Z-IETD-FMK: Mapping Caspase-8 in Immunity

  2026-08-19

  A translational framework for using Z-IETD-FMK to dissect caspase-8-dependent apoptosis, T cell activation, NF-κB signaling, and TRAIL responses while connecting infection biology with immune and cancer research.

• N-octanoyl-L-Homoserine lactone Assay Guide

  2026-08-18

  A scenario-based guide to using N-octanoyl-L-Homoserine lactone (SKU C3579) in viability, proliferation, cytotoxicity, and host–microbe experiments. It covers solvent compatibility, concentration planning, interpretation of C8-HSL-driven phenotypes, and practical product-selection criteria.

• Ruxolitinib (INCB018424) Assay Workflows

  2026-08-18

  Build pathway-resolved experiments with Ruxolitinib (INCB018424) across JAK-driven hematopoietic models and inflammatory monocyte assays. This practical guide connects dose selection, phospho-signaling, flow cytometry, and troubleshooting without treating a TLR4 study as direct evidence for JAK inhibition.

• BX795: PDK1 Inhibitor Workflows for Cancer

  2026-08-17

  BX795 supports acute, titratable interrogation of PDK1–AKT2 signaling while also enabling studies of TBK1, IKKε, and IRF3-dependent innate immunity. This guide pairs practical kinase, cancer-cell, and macrophage workflows with assay-design choices that distinguish growth arrest from true cell killing.

• 1-Phenyl-2-Pentanol and Hepatic Fibrosis

  2026-08-17

  The reference study evaluates 1-phenyl-2-pentanol, a compound identified from Moringa oleifera leaves, in TGF-β1-stimulated human hepatic stellate cells. By combining fibrosis-marker analysis, proteomics, and molecular docking, it links the compound’s anti-fibrotic activity to suppression of TGF-β1 and Wnt/β-catenin signaling while highlighting important limits of an in vitro model.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-08-16

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research tool for examining autophagy pathway modulation and toll-like receptor 7/9 signaling in autoimmune disease research. It is suited to short-term, water-based workflows, but should not be selected for protocols that require DMSO or ethanol solubility or long-term storage of prepared solutions.

8440 records 1/563 page Next 12345 下5页 Last page